These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1378787)

  • 21. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?
    Schneider W; Kober G; Roebruck P; Noack H; Alle M; Cieslinski G; Reifart N; Kaltenbach M
    Eur J Clin Pharmacol; 1990; 39 Suppl 1():S17-23. PubMed ID: 2261941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium antagonists in myocardial infarction.
    Zannad F; Sadoul N
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S16-9. PubMed ID: 1706009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of ischemia in acute myocardial infarction].
    Kiowski W
    Schweiz Med Wochenschr; 1990 Oct; 120(42):1531-8. PubMed ID: 1978408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium antagonists after acute myocardial infarction.
    Ferrario M; Specchia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S75-8. PubMed ID: 2483238
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.
    Jost S; Rafflenbeul W; Deckers J; Wiese B; Hecker H; Nikutta P; Lippolt P; Lichtlen P
    Eur J Epidemiol; 1992 May; 8 Suppl 1():107-19. PubMed ID: 1505647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacologic prevention of cardiovascular diseases with calcium antagonists].
    Rafflenbeul W
    Z Kardiol; 1992; 81 Suppl 4():211-20. PubMed ID: 1290301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
    Kern MJ
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Are all calcium antagonists alike?].
    Bertel O
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):164-7. PubMed ID: 1535950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate-lowering calcium antagonists in hypertensive post-myocardial infarction patients.
    Messerli FH; Hansen JF; Gibson RS; Schechtman KB; Boden WE
    J Hypertens; 2001 May; 19(5):977-82. PubMed ID: 11393682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-atherosclerotic and vasculoprotective actions of calcium antagonists.
    Ram CV
    Am J Cardiol; 1990 Dec; 66(21):29I-32I. PubMed ID: 2256466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.
    Yusuf S; Held P; Furberg C
    Am J Cardiol; 1991 Jun; 67(15):1295-7. PubMed ID: 2035457
    [No Abstract]   [Full Text] [Related]  

  • 35. The value of nifedipine in the treatment of hypertension, coronary heart disease and myocardial infarction (post-infarction therapy).
    Schulz J; Schmidt J; Rück W
    Curr Med Res Opin; 1996; 13(7):397-408. PubMed ID: 8862939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential therapy with calcium antagonists. Hemodynamic studies using nifedipine, verapamil and diltiazem].
    Lehmann HU; Hochrein H
    Dtsch Med Wochenschr; 1985 Apr; 110(17):674-80. PubMed ID: 3987531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Calcium antagonists and coronary heart disease. An overview].
    Gasser R; Eber B; Schwarz T; Schafhalter E; Klein W
    Wien Med Wochenschr; 1993; 143(19-20):500-9. PubMed ID: 8135032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.